Combining LINE-1 hypomethylation with other epigenetic markers, such as RASSF1A hypermethylation in HCC or AIM1 methylation in melanoma, has further enhanced prognostic accuracy and predicted early recurrence after surgery. The gene discussed is RASSF1; the disease is melanoma.